Loading data
ZOOZNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 247 k USD | 1.04 m USD | 764 k USD | — | — |
| Cost of revenue | 3.11 m USD | 1.53 m USD | 1.87 m USD | 178 k USD | — |
| Gross profit | -2.86 m USD | -486 k USD | -1.11 m USD | -178 k USD | — |
| Research and development expense | 3.74 m USD | 5.06 m USD | 5.22 m USD | 4.16 m USD | 1.52 m USD |
| Operating profit | -53.13 m USD | -10.54 m USD | -12.21 m USD | -8.2 m USD | -4.54 m USD |
| Interest expense | 160 k USD | 171 k USD | — | — | — |
| Profit before tax | — | — | -11.76 m USD | -7.83 m USD | -4.58 m USD |
| Net income (reported basis) | -55.59 m USD | -10.99 m USD | -11.76 m USD | -7.83 m USD | -4.58 m USD |
| Basic earnings per share | -0.94 USD/share | -1.09 USD/share | -1.99 USD/share | -1.51 USD/share | -2.27 USD/share |
| Diluted earnings per share | -0.94 USD/share | -1.09 USD/share | -1.99 USD/share | -1.51 USD/share | -2.27 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.